Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma

被引:78
作者
Flavin, Richard J. [1 ]
Smyth, Paul C.
Laios, Alexandros [2 ]
O'Toole, Sharon A. [2 ]
Barrett, Ciara
Finn, Stephen P.
Russell, Susan
Ring, Martina
Denning, Karen M.
Li, Jinghuan
Aherne, Sinead T.
Sammarae, Dania A. [2 ]
Aziz, Natasha A. [2 ]
Alhadi, Araibi [2 ]
Sheppard, Brian L. [2 ]
Lao, Kai [3 ]
Sheils, Orla M.
O'Leary, John J.
机构
[1] St James Hosp, Trinity Coll, Dept Histopathol, Dublin 8, Ireland
[2] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland
[3] Appl Biosyst Inc, Foster City, CA 94404 USA
关键词
microRNA; primary peritoneal carcinoma; chromosome; 17; PAPILLARY SEROUS CARCINOMA; EPITHELIAL OVARIAN-CARCINOMA; HUMAN LUNG CANCERS; BETA-CATENIN; EXPRESSION PROFILES; ALPHA-CATENIN; E-CADHERIN; REDUCED EXPRESSION; MOLECULAR EVIDENCE; UNIFOCAL ORIGIN;
D O I
10.1038/modpathol.2008.135
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
MicroRNAs are a group of small non-coding RNAs approximately 22 nucleotides in length. Recent work has shown differential expression of mature microRNAs in human cancers. We characterized the alteration in expression of a select group of microRNAs in primary peritoneal carcinoma relative to matched cases of ovarian serous carcinoma. MicroRNA expression was analysed using semi-quantitative stem-loop RT-PCR on a set of 34 formalin-fixed paraffin-embedded samples. Protein expression of p53 and bcl-2 was quantified in the corresponding tissue microarray. We provide definitive evidence that there is downregulation of a select group of microRNAs in tumours meeting Gynaecological Oncology Group criteria for primary peritoneal carcinoma relative to ovarian serous carcinoma. Specifically, we show decreased p53 expression and downregulation of miR-195 and miR-497 from the microRNA cluster site at chromosome 17p13.1 in primary peritoneal carcinoma relative to ovarian serous carcinoma. miR-195 and miR-497 may have potential roles as tumour-suppressor genes in primary peritoneal tumourigenesis.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 90 条
[1]   MAPPING OF THE 19P13 BREAKPOINT IN AN OVARIAN-CARCINOMA BETWEEN THE INSR AND TCF3 LOCI [J].
AMAN, P ;
PEJOVIC, T ;
WENNBORG, A ;
HEIM, S ;
MITELMAN, F .
GENES CHROMOSOMES & CANCER, 1993, 8 (02) :134-136
[2]   MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing [J].
Ambros, V .
CELL, 2003, 113 (06) :673-676
[3]   Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum [J].
Bandera, CA ;
Muto, MG ;
Welch, WR ;
Berkowitz, RS ;
Mok, SC .
ONCOGENE, 1998, 16 (26) :3455-3459
[4]   Comparison between primary peritoneal and epithelial ovarian carcinoma: A polpulation-based study [J].
Barda, G ;
Menczer, J ;
Chetrit, A ;
Lubin, F ;
Beck, D ;
Piura, B ;
Glezerman, M ;
Modan, B ;
Sadetzki, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :1039-1045
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   Primary peritoneal serous papillary carcinoma: A study of 25 and comparison with stage Ill-IV ovarian papillary serous carcinoma [J].
BenBaruch, G ;
Sivan, E ;
Moran, O ;
Rizel, S ;
Menczer, J ;
Seidman, DS .
GYNECOLOGIC ONCOLOGY, 1996, 60 (03) :393-396
[7]   MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis [J].
Bloomston, Mark ;
Frankel, Wendy L. ;
Petrocca, Fabio ;
Volinia, Stefano ;
Alder, Hansjuerg ;
Hagan, John P. ;
Liu, Chang-Gong ;
Bhatt, Darshna ;
Taccioli, Cristian ;
Croce, Carlo M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (17) :1901-1908
[8]   EXTRAOVARIAN PERITONEAL SEROUS PAPILLARY CARCINOMA - A CASE-CONTROL RETROSPECTIVE COMPARISON TO PAPILLARY ADENOCARCINOMA OF THE OVARY [J].
BLOSS, JD ;
LIAO, SY ;
BULLER, RE ;
MANETTA, A ;
BERMAN, ML ;
MCMEEKIN, S ;
BLOSS, LP ;
DISAIA, PJ .
GYNECOLOGIC ONCOLOGY, 1993, 50 (03) :347-351
[9]   Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - a Gynecologic Oncology Group Study [J].
Bloss, JD ;
Brady, MF ;
Liao, SY ;
Rocereto, T ;
Partridge, EE ;
Clarke-Pearson, DL .
GYNECOLOGIC ONCOLOGY, 2003, 89 (01) :148-154
[10]   Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration [J].
Bourguignon, Lilly Y. W. ;
Gilad, Eli ;
Peyrollier, Karine .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (27) :19426-19441